Long-term safety and efficacy of imatinib in pulmonary arterial hypertension

被引：0
|
作者：
Hoeper, Marius [1 ]
Barst, Robyn [2 ]
Galie, Nazzareno [3 ]
Hassoun, Paul [4 ]
Morrell, Nicholas [5 ,6 ]
Peacock, Andrew [7 ]
Simonneau, Gerald [8 ]
Tapson, Victor [9 ]
Torres, Fernando [10 ]
Lawrence, David [11 ]
Quinn, Deborah [12 ]
Ghofrani, Hossein Ardeschir [13 ]
机构：
[1] Med Hsch, Resp Med, Hannover, Germany
[2] Columbia Univ, Resp Med, New York, NY USA
[3] Azienda Osped Univ Bologna, Resp Med, Bologna, Italy
[4] Johns Hopkins Univ, Resp Med, Baltimore, MD USA
[5] Addenbrookes Hosp, Resp Med, Cambridge, England
[6] Papworth Hosp, Resp Med, Cambridge, England
[7] Golden Jubilee Natl Hosp, Resp Med, Glasgow, Lanark, Scotland
[8] Univ Paris Sud XI, Resp Med, Orsay, France
[9] Duke Univ, Med Ctr, Resp Med, Durham, NC USA
[10] UT Southwestern Med Ctr, Resp Med, Dallas, TX USA
[11] Novartis Horsham Res Ctr, Resp Med, Horsham, W Sussex, England
[12] Novartis Pharmaceut, Resp Med, Cambridge, MA USA
[13] Univ Hosp Giessen & Marburg GmbH, Resp Med, Giessen, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Pulmonary hypertension; Treatments;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3488
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of Imatinib Mesylate on Scleroderma Associated Pulmonary Arterial Hypertension
    Maki, H.
    Hatano, M.
    Yao, A.
    Imamura, T.
    Asada, K.
    Inaba, T.
    Shiga, T.
    Kinugawa, K.
    Nagai, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S212 - S213
  • [42] EFFICACY OF IMATINIB MESYLATE ON SCLERODERMA ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
    Maki, H.
    Hatano, M.
    Yao, A.
    Imamura, T.
    Inaba, T.
    Shiga, T.
    Kinugawa, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 238 - 239
  • [43] Long-term Effects of Epoprostenol on the Pulmonary Vasculature in Idiopathic Pulmonary Arterial Hypertension
    Rich, Stuart
    Pogoriler, Jennifer
    Husain, Aliya N.
    Toth, Peter T.
    Gomberg-Maitland, Mardi
    Archer, Stephen L.
    CHEST, 2010, 138 (05) : 1234 - 1239
  • [44] Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension
    Speich, Rudolf
    Treder, Ursula
    Domenighetti, Guido
    Huber, Lars C.
    Ulrich, Silvia
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (02) : 256 - 260
  • [45] Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension
    Rudolf Speich
    Ursula Treder
    Guido Domenighetti
    Lars C. Huber
    Silvia Ulrich
    International Journal of Clinical Pharmacy, 2014, 36 : 256 - 260
  • [46] LONG-TERM SAFETY AND EFFICACY OF CILAZAPRIL FOR MILD AMBULATORY HYPERTENSION
    FENSTER, R
    RUDD, P
    ZACHARY, V
    CLINICAL RESEARCH, 1989, 37 (01): : A120 - A120
  • [47] Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension
    Tamura, Yuichi
    Furukawa, Asuka
    Tamura, Yudai
    Yamada, Kenta
    Taniguchi, Hirohisa
    Fukuda, Keiichi
    Kawamura, Akio
    Satoh, Toru
    PULMONARY CIRCULATION, 2022, 12 (01)
  • [48] Efficacy and Safety of Treating Pulmonary Arterial Hypertension With Imatinib: A Meta-Analysis of Randomized Controlled Trials
    Chen, Xiaofa
    Xue, Bijuan
    Xu, Lina
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2025, 85 (03) : 177 - 185
  • [49] Long-term inhaled iloprost use in children with pulmonary arterial hypertension
    Alehan, Dursun
    Yildirim, Isil
    Sahin, Murat
    Ozkutlu, Suheyla
    Ozer, Sema
    Karagoz, Tevfik
    CARDIOLOGY IN THE YOUNG, 2012, 22 (04) : 396 - 403
  • [50] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Calcaianu, Mihaela
    Canuet, Matthieu
    Enache, Irina
    Kessler, Romain
    PULMONARY CIRCULATION, 2017, 7 (02) : 439 - 447
12345